GlassScriptPhysician profile
Robert Kingsbury Botta
NPI 1780094326
$50,196.95
in general payments reported to CMS, 2019-2025
35 companies · $6,398 in 2025
The $6,398 reported for 2025 was more than what 87% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $289 · 2021: $968 · 2022: $5,518 · 2023: $19K · 2024: $18K · 2025: $6,398.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $34K · Food and Beverage: $4,813 · Consulting Fee: $4,275.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $34,333.33 |
| Food and Beverage | $4,813.35 |
| Consulting Fee | $4,275.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $36,758.09 | 2022-2025 | Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac |
| Cardiovascular Systems INC. | $6,249.93 | 2020-2023 | Diamondback Peripheral |
| Boston Scientific Corporation | $1,471.41 | 2020-2025 | Ekosonic, Eluvia, General - Vascular Intervention |
| Inari Medical, INC. | $1,350.27 | 2023-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Medtronic, INC. | $1,146.55 | 2021-2025 | Abre, Venaseal, Endurant Iis |
| Silk Road Medical, INC. | $446.73 | 2022-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Endologix LLC | $386.55 | 2022-2024 | Alto Abdominal Stent Graft System |
| Reapplix INC. | $325.07 | 2022-2024 | 3c Patch Kit - Box |
| Stryker Corporation | $270.61 | 2025 | Artix Mt, Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Janssen Pharmaceuticals, INC | $227.08 | 2021-2023 | Xarelto |
| Lemaitre Vascular, INC. | $196.11 | 2021-2025 | Artegraft Vascular Graft, Restoreflow, Trivex System |
| E.R. Squibb & Sons, L.L.C. | $173.87 | 2022-2025 | Eliquis |
| Penumbra, INC. | $147.45 | 2021 | |
| Pfizer INC. | $140.52 | 2021-2024 | |
| Csl Behring | $124.97 | 2022 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $122.45 | 2020 | |
| Musculoskeletal Transplant Foundation INC. | $72.89 | 2021 | |
| Solventum Corporation | $72.14 | 2025 | Prevena, V.A.C.Ulta, Activ.A.C. |
| Abbott Laboratories | $64.37 | 2023-2025 | Esprit, Jeti Peripheral Catheter |
| Smith+Nephew, INC. | $61.50 | 2020-2021 | |
| Tactile Systems Technology INC | $50.20 | 2022-2024 | Entre Plus, Flexitouch Plus |
| Cardiva Medical, INC. | $46.86 | 2023-2024 | Cardiva Vascade 6/7f Vcs |
| Organogenesis INC. | $36.08 | 2021-2022 | |
| Bard Peripheral Vascular, INC. | $33.99 | 2025 | Lutonix Drug Coated Balloon |
| Cordis US Corp. | $32.85 | 2022-2024 | Mynx Control |
| Cook Medical LLC | $29.89 | 2021-2023 | Advance |
| Next Science LLC | $19.67 | 2023-2025 | Xperience, Blastx, Surgx |
| Cagent Vascular INC | $19.32 | 2024 | Serrantor |
| Mimedx Group, INC. | $18.61 | 2025 | |
| Convatec INC. | $18.51 | 2023 | |
| Shockwave Medical, INC | $18.41 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Paratek Pharmaceuticals, INC. | $18.11 | 2023 | Nuzyra |
| Reprise Biomedical, INC. | $17.58 | 2023 | Miro3d |
| Biotronik INC. | $15.75 | 2022 | |
| W. L. Gore & Associates, INC. | $12.56 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Botta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.